Home / Market News / $IMAX
benzinga Corporate Catalyst Impact 55/100 ● positive

Wedbush Maintains Outperform on Imax, Raises Price Target to $60

Oct 14, 2026, 12:32 PM UTC · Primary ticker $IMAX

Wedbush analyst Alicia Reese has reiterated an Outperform rating for Imax and increased its price target from $54 to $60. This indicates a positive outlook from the analyst, suggesting potential upside for the stock based on their valuation.

Wedbush analyst Alicia Reese has maintained an 'Outperform' rating on Imax and raised the price target from $54 to $60. This action signals continued confidence in Imax's performance and future prospects from a prominent investment bank. For traders, this could be seen as a positive signal, potentially leading to short-term upward momentum for IMAX stock as investors react to the increased price target. The long-term implication is that Wedbush believes Imax has further growth potential, which could attract more institutional interest. The key opportunity for traders is to capitalize on any immediate positive sentiment, while the risk lies in whether the market fully aligns with Wedbush's valuation.

$IMAX positive Analyst price target increase
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.